153 related articles for article (PubMed ID: 25423346)
1. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Kalinyak JE; Berg WA; Schilling K; Madsen KS; Narayanan D; Tartar M
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):260-75. PubMed ID: 24085500
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Diagnostic Performance of Three-Dimensional Positron Emission Mammography versus Whole Body Positron Emission Tomography in Breast Cancer.
Dai D; Song X; Wang M; Li L; Ma W; Xu W; Ma Y; Liu J; Zhang J; Liu P; Gu X; Su Y
Contrast Media Mol Imaging; 2017; 2017():5438395. PubMed ID: 29097927
[TBL] [Abstract][Full Text] [Related]
4. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Eo JS; Chun IK; Paeng JC; Kang KW; Lee SM; Han W; Noh DY; Chung JK; Lee DS
Breast; 2012 Feb; 21(1):66-71. PubMed ID: 21871801
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
[TBL] [Abstract][Full Text] [Related]
6. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
Schilling K; Narayanan D; Kalinyak JE; The J; Velasquez MV; Kahn S; Saady M; Mahal R; Chrystal L
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):23-36. PubMed ID: 20871992
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
[TBL] [Abstract][Full Text] [Related]
8. Newly-Developed Positron Emission Mammography (PEM) Device for the Detection of Small Breast Cancer.
Yanai A; Itoh M; Hirakawa H; Yanai K; Tashiro M; Harada R; Yoshikawa A; Yamamoto S; Ohuchi N; Ishida T
Tohoku J Exp Med; 2018 May; 245(1):13-19. PubMed ID: 29731479
[TBL] [Abstract][Full Text] [Related]
9. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Berg WA; Weinberg IN; Narayanan D; Lobrano ME; Ross E; Amodei L; Tafra L; Adler LP; Uddo J; Stein W; Levine EA;
Breast J; 2006; 12(4):309-23. PubMed ID: 16848840
[TBL] [Abstract][Full Text] [Related]
10. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
Eur J Surg Oncol; 2018 Apr; 44(4):444-448. PubMed ID: 29396328
[TBL] [Abstract][Full Text] [Related]
11. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG.
Murthy K; Aznar M; Thompson CJ; Loutfi A; Lisbona R; Gagnon JH
J Nucl Med; 2000 Nov; 41(11):1851-8. PubMed ID: 11079494
[TBL] [Abstract][Full Text] [Related]
12. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
[TBL] [Abstract][Full Text] [Related]
13. A preliminary report of breast cancer screening by positron emission mammography.
Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Kalinyak JE
AJR Am J Roentgenol; 2012 Jan; 198(1):219-32. PubMed ID: 22194501
[TBL] [Abstract][Full Text] [Related]
15. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
Sakaguchi R; Kataoka M; Kanao S; Miyake KK; Nakamoto Y; Sugie T; Toi M; Mikami Y; Togashi K
Ann Nucl Med; 2019 Aug; 33(8):570-578. PubMed ID: 31115856
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Berg WA; Madsen KS; Schilling K; Tartar M; Pisano ED; Larsen LH; Narayanan D; Ozonoff A; Miller JP; Kalinyak JE
Radiology; 2011 Jan; 258(1):59-72. PubMed ID: 21076089
[TBL] [Abstract][Full Text] [Related]
17. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
Sueoka S; Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
Breast Cancer Res Treat; 2021 May; 187(1):125-133. PubMed ID: 33484374
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of dedicated breast positron emission tomography.
Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of dedicated breast PET for the assessment of residual tumor after neoadjuvant chemotherapy.
Koyasu H; Goshima S; Noda Y; Nishibori H; Takeuchi M; Matsunaga K; Yamada T; Matsuo M
Jpn J Radiol; 2019 Jan; 37(1):81-87. PubMed ID: 30392134
[TBL] [Abstract][Full Text] [Related]
20. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
